2. Definition
⢠Any lesion caused by unrelieved
pressure leading damage of underlying
tissue
â Synonymous to decubitus ulcer and
bedsores but the above term denotes the
primary pathophysiologic factor
3. Staging
⢠Stage I
â Nonblanchable erythema of intact skin;
may also be other discoloration, warmth,
edema and induration
â 10-fold increase in risk of developing
higher-staged ulcers
4. ⢠Stage II
â Partial-thickness skin loss involving the
epidermis or also the dermis
⢠Stage III
â Extend to the subcutaneous tissues and
deep fascia
â Typically show undermining
⢠Stage IV
â Involve muscle and bone
11. ⢠Eschar formation
â Full-thickness injury
â Has to be removed
prior to staging
⢠Pressure-related
blister formation
â Cannot be staged
clinically
12. Epidemiology
⢠Acute care setting
â Stage II and higher prevalence 3-11%,
incidence 1-3%
â After 1 week of confinement, incidence
28%, prevalence 8-30%
â >50% occur in patients >70 years old
13. ⢠In nursing homes
â Prevalence of 20-33% and incidence of 11-
14%
⢠Sepsis
â Most serious complication of pressure
ulcers
â In-house mortality of 60% when the ulcer is
the source of bacteremia
14. ⢠Infected pressure ulcers
â Most common infection in skilled nursing
facilities (6% of residents)
⢠Osteomyelitis
â In 26% of non-healing pressure ulcers
15. ⢠Associated with prolonged and
expensive hospitalizations
⢠Associated with pain
â 59-85% of those who can communicated
describe pain
â 45% report ulcer pain as âhorribleâ
16. ⢠Increased mortality
â 60% at 1 year after discharged for those
who develop a pressure ulcer
17. Pathophysiology
⢠4 factors implicated: pressure, shearing
forces, friction and moisture
⢠Muscle and subcutaneous
tissueď more sensitive to pressure
injury
18.
19. ⢠Pressure on bony prominences
â 100-150 mmHg on regular mattress while
lying down
â 300 mmHg on ischial tuberosities while
sitting
â Enough to decrease transcutaneous
oxygen tension to 0
⢠Other factors may lower the time or
pressure needed to cause full-thickness
injuries
20. ⢠Shearing forces-tangential forces on the
skin when the patient slides while sitting
or lying down in an elevated position
â Lowers the pressure needed to cause
ulcers
⢠Friction leads to intraepidermal
blistersď unroofed, leading to
superficial erosions
⢠Moistureď may lead to maceration
21.
22.
23. ⢠Effect of pressure
â Ischemia and accumulation of cellular
toxins
â Damage begins in deeper tissues
â Persistent pressureď vascular leakage and
interstitial edemaď eventual hemorrhage
(stage I)
⢠Superimposed bacterial infection (both
deep and superficial)
24.
25. Presentation
⢠Any disease that leads to immobility
predisposes to pressure ulcers
⢠Risk factors other than immobility
â Incontinence (particularly fecal)
â Nutritional factors (decreased lymphocyte
count, hypoalbuminemia, inadequate
intake, decreased body weight, depleted
triceps skin fold)
26. ⢠Other factors
â Dry skin
â Increased body temperature
â Decreased blood pressure
â Age
â Age-related skin changes
27. Assessment
⢠Includes assessment of risk factors,
including nutritional assessment
⢠Location, size, stage and wound
characteristics of ulcer at onset
â Includes assessment of tracts,
undermining, tunneling, exudate, necrotic
tissue, granulation and epithelialization
28.
29. ⢠Follow-up assessment using above
parameters at least weekly
â PUSH score
â Decrease in ulcer size over 2 weeks usually
predicts healing
⢠Sinograms to assess tract extent
⢠Cultures using needle aspiration or biopsy
speciments; may include bone biopsys
â Culture of swabs not helpful as bacterial
colonization in eventual
â Important if ulcer does not heal after 4 weeks or if
with obvious infection
30.
31.
32. ⢠Osteomyelitis diagnosis may be difficult
due to similarity of pressure-induced
bone changes
â Presence of abnormal plain radiograph,
WBC count of 15,000 and ESR >120 mm
has probability of osteomyelitis of 70%
33. ⢠Most common bacterial isolates
â Gram (-) aerobic rods (45% of isolates)
â Gram (+) aerobic cocci (39%)
â Bacteroides species, most common
anaerobic isolate
34. Management
Pharmacologic
⢠Vitamin and mineral supplementation for
those with deficiencies
⢠Systemic antibiotics indicated for patients with
â Sepsis
â Cellulitis
â Osteomyelitis
â Prevention of bacterial endocarditis in those with
VHD and requiring debridement
35. ⢠Broad spectrum antibiotics for those
with suspected bacteremia, pending
culture results
â Ampi-sulbactam
â Carbapenems
â Pip-tazo
â Clindamycin/metronidazole + quinolones
36. ⢠Vancomycin for methicillin-resistent
Staphylococcus aureus
⢠Deeper ulcers may have some benefit
for topical antibiotics
â Silver sulfadiazine x 2 weeks
â Avoid iodophors, sodium hypochlorite or
acetic acid (toxic to fibroblast)
37. Nonpharmacologic
⢠Adequate dietary, especially protein
intake
â Target 30-35 kcal/kg BW/day with 1.25-
1.50 g CHON/kg BW
â May use alternative feeding methods if oral
intake is inadequate
â Vitamin and mineral supplementation
38. ⢠Use of pressure-relieving devices
â Regular air/foam mattresses
â Egg-crate foam mattresses
â Static mattresses (should not bottom out
and provide at least 2.5 cm of support)
⢠Usually appropriate for those who can still
assume different positions
â Dynamic mattresses
⢠Air-fluidized mattresses
⢠Low-air loss mattresses
39.
40.
41.
42. ⢠Debridement
â Sharp debridement
â Mechanical approaches (wet-to-dry
dressing, irrigation, hydrotherapy)
⢠Irrigation pressure 4-15 psi using a 30-cc
syringe with a 18G needle
â Enzymatic approaches (collagenases)
â Autolytic approaches (contraindicated in
infected ulcers)
43. ⢠Occlusive dressings for clean wound
â Not proven to me more effective for stage
III or IV ulcers but reduces the nursing time
needed
⢠Moist gauze dressing using normal
saline for the ulcer base
⢠The aim of dressing the ulcer is to
maintain a moist environment for would
healing and autolytic debridement
44.
45.
46. ⢠Skin sealants
â Prevents friction and
protects from adhesives
â Contains alcohol and
should not be used under
most hydrocolloids
47. ⢠Impregnated gauze
â Gauze impregnated with
saline or other
substances
â Make sure that
impregnating substance
is not harmful to wound
healing
â Limited absorbent
capacity
48. ⢠Composite dressings
â Combination of
different dressing
groups
â Properties depend on
the components
49. ⢠Transparent film dressing
â Polyurethane and
polyethylene membrane
coated with a layer of
acrylic, hypoallergenic
adhesive
â Promotes epithelialization,
moist wound healing
â Bacterial barrier, autolysis
â May reinjure wound on
removal
â Can lead to wound edge
maceration
â Not for wounds with
moderate to heavy
exudation
50. ⢠Hydrocolloid
â Gelatin or
carboxymethycellulose in a
polyisobutylene adhesive
base
â Moist would healing with
absorption of light to
moderate wound fluid
â Increased wear time
â Reduces pain, promotes
autolysis
â Not for those withg heavy
exudate
â Odor on removal
â Limited absorption
51. ⢠Hydrogels
â May or may not have
supporting fabric net
â High water content with
varying gel forming material
â Moist wound healing with low
to moderate drainage
â Promotes autolysis
â Reduces pain and rehydrates
dry wounds; cooling effect
â Does not cause reinjury on
removal
â Can dry out or may macerate
surrounding tissues
â Candidiasis may occur with
inappropriate use
52. ⢠Wound fillers
â Made of copolymer
starch or dextranomer
beads which absorb
wound fluid to form a gel
â Moderate to large
absorption and fills up
dead space
â Moisture retentive and
promotes autolysis
â Requires another
dressing to hold it in
â May have an odor
â Requires wound irrigation
to remove
53. ⢠Enzyme debriding
agent
â Can debride necrotic
tissue
â Hard eschar chould be
removed first
â Discontinued when
granulation appears
â Require secondary
dressing
â May be inhibited by
irrigation solutions
54. ⢠Alginates
â Calcium or sodium salts
of alginic acid
â Moisture retentive and
promotes autolysis
â Moderate to large
moisture absorption
â Reduces pain and can fill
dead space
â Should not be used in
low-exudate wounds and
may dry out
55. ⢠Lubricating agents
â Promotes moist wound
healing
â Limited autolysis
â Reduces pain
â Requires secondary
dressing
â Non-absorptive
â May be used to
impregnate gauze
56. ⢠Foams
â Hydrophilic and non-
adherent modified
polyurethane foam
â In wafers, pillows; with
film covers
â Surfactant impregnated
or with a charcoal layer
â Moderate to large
absorption
â Moist wound healing
â Can be used with topical
medications and
infected wounds
â Requires taping
57. ⢠Collagen
â Bovine collagen attached to
nylon mesh, or powder or
paste
â Also comes in 90% collagen
and 10% alginate
â Absorbs small to moderate
exudate
â Non-adherent
â For contaminated, infecteed
wounds
â Can be used with topical
agents
â Requires secondary dressing
â Sensitivity to bovine material
58. ⢠Surgical correction (attempted only in
clean wounds)
â Primary closure
â Skin grafting
â Myocutaneous flaps
⢠30% complication rate
⢠Complications included necrosis, dehiscence,
flap infection, hematoma
⢠70% healing rate by time of discharge
â Removal of underlying bony prominences
59. ⢠Other modalities
â Hyperbaric oxygen therapy
⢠Effects not statistically significant
â Growth factors
⢠For ulcers that do not heal with a
comprehensive approach
â Larvae therapy
â Vacuum-assisted closure
⢠Reduces bacterial load and improves perfusion
and granulation
â Electrical stimulation
⢠Improves healing in small trials; dose and type
of wound to be applied with not yet determined
60. Prevention
⢠Systematic risks assessment
â Braden scale
⢠A score of 18 or less in any patient indicates
risk for pressure ulceration
â Norton scale
61.
62.
63. ⢠Appropriate skin care
â Systematic skin inspection
â Skin cleaning with mild cleansing agent at
time of soiling and at regular intervals
â Minimize skin dryingď use moisturizers
â Minimize excessive moisture
â Minimize friction and shear forces
â Ensure adequate dietary intake
64. ⢠Frequent repositioning every 2 hours for supine
patients
â The back should be at a 30° angle with the support
surface; avoid a 90° angle
â Minimize head elevation to compelling indications like
postfeeding or if in respiratory distress
⢠If patient needs to be seated, should not be for
more than 1 hour; positions are shifted every 15-
30 minutes
â May use pillows behind the knees, back or neck to
provide more support
â Avoid doughnut rings (increases venous congestion)
65. ⢠Off-loading devices of extremities in the
supine or seated position
⢠Sheepskin and foam egg crate mattress
(or other foam overlays)
â Inexpensive but do not have the capability
of reducing pressure enough to reduce
injury
⢠Use of pressure-relieving mattresses
â 60% reduction in incidence of pressure
ulcers
66. ⢠Treatment of infections distant from
clean pressure ulcers
â Bacteremia from distant infections may
seed in the clean ulcer due to least
resistance